Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline(Historical earnings: For 2026Q1 (period ended 2026-03-31), Hims & Hers Health reported basic EPS of -0.4 and diluted EPS of -0.4, with net income of USD -92.115 million. In the prior-year period (2025-03-31), basic EPS was 0.22, diluted EPS was 0.2, and net income was USD 49.485 million. For 2025FY (period ended 2025-12-31), basic EPS was 0.57, diluted EPS was 0.51, and net income was USD 0.128 billion, compared with 2024FY basic EPS of 0.58, diluted EPS of 0.53, and net income of USD 0.126 billion. Consensus expectations: For 2026Q2 (event date 2026-08-10), consensus EPS estimate is -0.0143. For 2026Q3 (event date 2026-11-09), consensus EPS estimate is 0.07 and revenue estimate is USD 0.911 billion. For 2026Q4 (event date 2027-02-22), consensus EPS estimate is 0.128 and revenue estimate is USD 0.973 billion.)